ENHANC3D GENOMICS LTD

Company number 12423696

0 active persons with significant control / 1 active statement

Statement (Active)

• Notified on: 2 September 2022

Bioqube Factory Fund I Commv (Ceased)

• Correspondence address: 13 Barricadenplein, Brussels, Belgium, B-1000
• Notified on: 30 March 2021
• Ceased on: 2 September 2022
• Governing law: The Company Act In Belgium
• Legal form: Commv
• Nature of control: Ownership of shares – More than 25% but not more than 50%

Prof Peter John Fraser (Ceased)

• Correspondence address: Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
• Notified on: 8 December 2020
• Ceased on: 1 April 2021
• Date of birth: May 1956
• Nationality: American
• Country of residence: United States
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%

Dr Mikhail Spivakov (Ceased)

• Correspondence address: Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
• Notified on: 24 January 2020
• Ceased on: 5 August 2020
• Date of birth: April 1980
• Nationality: British
• Country of residence: United Kingdom
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%
• Nature of control: Right to appoint or remove directors

Dr Stefan Walter Schoenfelder (Ceased)

• Correspondence address: Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
• Notified on: 24 January 2020
• Ceased on: 5 August 2020
• Date of birth: July 1973
• Nationality: German
• Country of residence: United Kingdom
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%
• Nature of control: Right to appoint or remove directors

Prof Peter John Fraser (Ceased)

• Correspondence address: Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
• Notified on: 24 January 2020
• Ceased on: 5 August 2020
• Date of birth: May 1956
• Nationality: American
• Country of residence: United States
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%
• Nature of control: Right to appoint or remove directors